EXIT 60-75% of position; retain 25-40% maximum for optionality only; redeploy capital to cash, short-duration Treasuries, or cleaner risk profiles

• FCF coverage of 2.5x looks comfortable today, but Eliquis LOE (13B in revenue) could shave 4-5B in lost high-margin revenue, threatening dividend sustainability
• Dividend cut triggers single-session gap down of 8-12%; no gradual repricing or trim-on-strength exit available
• 200 SMA at 58.62 is a tripwire that triggers forced selling from trend-following funds, pension rebalancing, and algorithmic risk models
• Stop at 57.50 provides only 93 cents of margin above a major technical level, insufficient protection against stop-hunts
• Beta 0.23 is irrelevant in abnormal regime with 10-year Treasury at highest yield since 2002 and Fed warning on inflation
• Prediction markets pricing 97% odds of zero rate cuts in 2026 creates hostile macro environment for long-duration assets
• Sentiment vacuum (both institutional and retail silent) is a leading indicator of asymmetric downside, not a sign of digested news
• Conservative drawdown expectation is 20-30% over 6-12 months if Eliquis LOE is moderately worse than consensus
• Retention rationale is optionality (potential upside from Cobenfy ramp or pipeline surprises), not dividend income
• Capital can be redeployed if thesis improves; cannot recover losses from a 10% gap-down on dividend cut announcement

→ vs aggressive: Asymmetric risk management claim is incorrect; downside is not smaller than upside when 200 SMA break leads to 52-week low at 52.85, not the 57.50 stop level

→ vs aggressive: Trim plan (30-40% exit, 60-70% core) is 'polite withdrawal' not 'defensive posture' given known structural event timing and lack of gradual exit capability

→ vs neutral: Reading sentiment correctly but drawing wrong conclusion; narrative vacuum precedes forced selling under time pressure, not a stabilizing bid

TRIM 35-45% / RETAIN 55-65% AS CORE with 57.50 hard stop and 60.50 trailing stop trigger; diversify trim proceeds into defensive sectors rather than cash

• BMY FCF of $12.8 billion provides 2.5x dividend coverage; even at $8 billion FCF post-LOE coverage remains 1.6x
• MACD histogram contracted five-fold from negative 0.61 to negative 0.12, signaling fading downside momentum
• RSI recovered from 32.6 to 43.1 with Bollinger lower band bounce on September 23rd indicating support test and consolidation
• 200 SMA at $58.62 is structurally intact and untested; current price $62.40 sits $3.78 above this level
• Existing 57.50 stop already provides protection against 200 SMA tripwire scenario the conservative analyst identified
• Cobenfy ramp and pipeline compounds not captured in static models; management has business development and cost levers
• Beta 0.23 reflects cash flow stability and income bid support; pharma dividend cuts are rare and telegraphed through visible signals absent here
• Aggressive analyst overplays breakdown by trading unconfirmed signals as confirmed; conservative analyst overcorrects by protecting against risks already addressed by stop-loss
• Sell 60-75% of position solves for a problem the stop already covers and sacrifices dividend income and optionality unnecessarily
• Absence of catalyst is neutral condition, not bearish; flows and macro tape drive price until narrative resets
• Diversify trim proceeds into utilities, consumer staples, or healthcare ETFs rather than cash to achieve genuine risk reduction

→ vs aggressive: MACD histogram contraction from negative 0.61 to negative 0.12 is five-fold downside momentum fade, not just sellers taking profits; RSI recovery and Bollinger band bounce indicate consolidation not free fall

→ vs aggressive: Dividend not in imminent danger - 2.5x coverage with management levers (cost programs, BD, buyback suspension) available; treating multi-year erosion curve as overnight event is analytical error

→ vs aggressive: 200 SMA at $58.62 is $3.78 above current price and structurally intact; cannot trade weekly close below $58.62 as if it has already occurred

→ vs aggressive: Cobenfy analysis is static snapshot ignoring ramp trajectory, pipeline compounds, and management navigation ability

→ vs aggressive: Calling conservative dividend thesis 'intellectually bankrupt' is rhetorical flourish not defensible analytical position

→ vs conservative: 20-30% drawdown scenario requires worst-case cascade not supported by data; beta 0.23 and income bid provide downside buffer

→ vs conservative: 200 SMA tripwire already protected by existing $57.50 stop sitting 93 cents below $58.62 level; selling 60-75% for unconfirmed risk is capitulation not prudence

→ vs conservative: 'We can always re-enter' logic fails - timing problem works in reverse; waiting for better entry means chasing on bounce from $60 support or 200 SMA

→ vs conservative: Trimming 75% of position with 2.5x covered dividend and intact long-term trend sacrifices genuine defensive value without proportional risk reduction

→ vs conservative: Dividend cut is tail risk not binary outcome; management has strong incentives to avoid it given equity comp and capital access implications